Table 1 Baseline demographics, comorbidities, and cardiac function obtained from the study cohort
From: Quality of life and frailty outcomes following surgical and transcatheter aortic valve replacement
Average baseline characteristic | SAVR n = 100 | TAVR n = 100 | CABG n = 100 |
|---|---|---|---|
Mean age | 65.94 (SD 11.6) | 82.87 (SD 6.9) | 65.90 (SD 10.0) |
Gender (male) | 79/100 | 80/100 | 79/100 |
Diabetes mellitus | 19/100 | 38/100 | 46/100 |
Hypertension | 56/100 | 69/100 | 74/100 |
Previous stroke/TIA | 5/100 | 6/100 | 11/100 |
AF | 10/100 | 32/100 | 6/100 |
eGFR < 90 ml/min | 1/100 | 26/100 | 8/100 |
Pulmonary HTN | 2/100 | 2/100 | 0/100 |
COPD | 13/100 | 12/100 | 14/100 |
Existing PPM | 1/100 | 13/100 | 0/100 |
PVD | 1/100 | 10/100 | 2/100 |
NYHA class | 2.23 (SD 0.7) | 2.61 (SD 0.6) | 1.13 (SD 0.4) |
LVEF | 57.95 (SD 8.4) | 54.62 (SD 11.8) | 54.33 (SD 11.0) |
AVA cm2 | 0.99 (SD 0.5) | 0.82 (SD 0.3) | 2.67 (SD 0.7) |
Mean AV gradient | 46.57 (SD 15.4) | 41.10 (SD 13.8) | 5.71 (SD 4.9) |
History of CAD | 11/100 | 49/100 | 100/100 |
STS score (%) | 1.18 (SD 0.4) | 4.82 (SD 3.0) | 0.77 (SD 0.4) |
Cohort mortality | 2/100 | 7/100 | 0/100 |